Biomarker

A biomarker is a measurable biological signal, often a protein, gene, or other substance in blood, tissue, or fluid, that gives information about a disease. Doctors use biomarkers to help detect illness, gauge how severe it is, or track how it responds to treatment. In mesothelioma, certain proteins released by tumor cells can serve as biomarkers.

Origin

The term combines "biological" and "marker" and came into wide scientific use in the late 20th century, as laboratory methods made it possible to measure specific molecules tied to disease. Its role in cancer grew with advances in blood testing and molecular biology.

Significance in Asbestos Context

For mesothelioma, biomarkers such as mesothelin (measured as SMRP, soluble mesothelin-related peptide), fibulin-3, and osteopontin can support a diagnosis and help monitor the disease, though none is reliable enough to diagnose mesothelioma on its own. A rising biomarker level may signal that a tumor is growing or returning. Biomarkers are helpers, not proof; a firm diagnosis still rests on biopsy and pathology. For patients, biomarker results in the medical record can add supporting weight to the clinical picture, but the core evidence for a claim remains the tissue diagnosis and the exposure history.

Example Sentence

Her oncologist tracked the mesothelin biomarker in her blood to help judge whether the tumor was responding to treatment.

Related Terms

Mesothelin, SMRP, Histopathology, Immunohistochemistry, Diagnosis, Osteopontin

Notes

• Ask whether biomarker tests like mesothelin (SMRP) are being used to monitor treatment response, and understand they support rather than replace a biopsy.
• Don't rely on a normal biomarker result to rule out disease; biopsy and imaging remain the definitive tests.
• Keep serial biomarker results together; the trend over time is more meaningful than any single value.